AIM: In June 2006, the human papillomavirus (HPV) vaccine, Gardasil, was licensed for use in the United States. We examined whether paediatricians would recommend the vaccine, obstacles they encountered and characteristics associated with not recommending the HPV vaccine to all eligible patients. METHODS: Four hundred fifty general paediatricians, 200 members of the section of infectious diseases and 200 members of the section of adolescent medicine of the American Academy of Pediatrics web-based directory were surveyed. RESULTS: Of 752 eligible paediatricians, 373 (50%) responded. Eighty-eight percent (292 of 332) of respondents stated that they would give the vaccine to all, 36 (11%) would give it to some and 4 (1%) would give it to none of their eligible patients. The main obstacles were cost and safety; a minority expressed concern about the vaccine's potential impact on adolescent sexual activity. Physicians who would not recommend HPV vaccination to all eligible patients were more likely to be generalists, have higher intrinsic religiosity, self-describe as conservative, report later adoption of new drugs/vaccines, and would not encourage vaccinating their own daughter or the daughter of a close friend. CONCLUSION: Although paediatricians are highly supportive of the HPV vaccine, certain characteristics may predict reluctance to immunize.
AIM: In June 2006, the human papillomavirus (HPV) vaccine, Gardasil, was licensed for use in the United States. We examined whether paediatricians would recommend the vaccine, obstacles they encountered and characteristics associated with not recommending the HPV vaccine to all eligible patients. METHODS: Four hundred fifty general paediatricians, 200 members of the section of infectious diseases and 200 members of the section of adolescent medicine of the American Academy of Pediatrics web-based directory were surveyed. RESULTS: Of 752 eligible paediatricians, 373 (50%) responded. Eighty-eight percent (292 of 332) of respondents stated that they would give the vaccine to all, 36 (11%) would give it to some and 4 (1%) would give it to none of their eligible patients. The main obstacles were cost and safety; a minority expressed concern about the vaccine's potential impact on adolescent sexual activity. Physicians who would not recommend HPV vaccination to all eligible patients were more likely to be generalists, have higher intrinsic religiosity, self-describe as conservative, report later adoption of new drugs/vaccines, and would not encourage vaccinating their own daughter or the daughter of a close friend. CONCLUSION: Although paediatricians are highly supportive of the HPV vaccine, certain characteristics may predict reluctance to immunize.
Authors: Deborah A Gust; Allison Kennedy; Irene Shui; Philip J Smith; Glen Nowak; Larry K Pickering Journal: Am J Prev Med Date: 2005-08 Impact factor: 5.043
Authors: Matthew F Daley; Nicole Liddon; Lori A Crane; Brenda L Beaty; Jennifer Barrow; Christine Babbel; Lauri E Markowitz; Eileen F Dunne; Shannon Stokley; L Miriam Dickinson; Stephen Berman; Allison Kempe Journal: Pediatrics Date: 2006-12 Impact factor: 7.124
Authors: J M Riedesel; S L Rosenthal; G D Zimet; D I Bernstein; B Huang; D Lan; J A Kahn Journal: J Pediatr Adolesc Gynecol Date: 2005-12 Impact factor: 1.814
Authors: Jessica A Kahn; Gregory D Zimet; David I Bernstein; Jeremy M Riedesel; Dongmei Lan; Bin Huang; Susan L Rosenthal Journal: J Adolesc Health Date: 2005-12 Impact factor: 5.012
Authors: Kenneth M Boyer; Ellen Holfels; Nancy Roizen; Charles Swisher; Douglas Mack; Jack Remington; Shawn Withers; Paul Meier; Rima McLeod Journal: Am J Obstet Gynecol Date: 2005-02 Impact factor: 8.661
Authors: Teri L Malo; Anna R Giuliano; Jessica A Kahn; Gregory D Zimet; Ji-Hyun Lee; Xiuhua Zhao; Susan T Vadaparampil Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-07-15 Impact factor: 4.254